AVITA Medical (RCEL) Capital Expenditures Growth (1y) (2020 - 2025)
AVITA Medical (RCEL) Capital Expenditures Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 27.22% |
| 10 | AVITA Medical | 109.91 Mn | 91.73 Mn | 14.31 Mn | -257.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -257.53% |
| Sep 30, 2025 | 2,223.08% |
| Jun 30, 2025 | 93.54% |
| Mar 31, 2025 | -80.73% |
| Dec 31, 2024 | -170.37% |
| Sep 30, 2024 | 113.86% |
| Jun 30, 2024 | -369.23% |
| Mar 31, 2024 | 303.87% |
| Dec 31, 2023 | 69.05% |
| Mar 31, 2023 | 343.75% |
| Mar 31, 2022 | -80.37% |
| Sep 30, 2021 | 34.00% |
| Mar 31, 2021 | -21.07% |
| Dec 31, 2020 | 1,305.71% |
| Sep 30, 2020 | -41.86% |